Vivatides Therapeutics
Develops extrahepatic RNA-targeting therapeutics
$54MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops extrahepatic RNA-targeting therapeutics
Building a unified robotics foundation model for controlling robots